Skip Navigation
left arrowGo back to In the News Page

Missouri Technology Corp. Invests $6.1M in Startups, Including Funding for Two Cortex-Connected Companies

May 08, 2026

sentiar.jpg

by St. Louis Business Journal

The Missouri Technology Corp. will make over $2 million in equity-based investments in its latest funding round, and said it will increase its maximum investments in the next funding round.

The public-private partnership, created by the Missouri General Assembly, focuses on fostering entrepreneurship in the state.

MTC said Tuesday that its board approved the funding for eight startups – seven of which are based in St. Louis – in its April investment award cycle through MTC's IDEA Fund. MTC's Innovation, Development and Entrepreneurial Advancement, or IDEA, fund is a state-sponsored venture capital initiative that uses public funding from Missouri and the federal government, according to the MTC website.

Through MTC's Venture Capital program for Series A or later-stage companies raising $5 million to $20 million, funding was awarded three startups including:

  • SweetSpot, of St. Louis, uses device data to improve diabetes care, providing virtual continuous glucose monitor device monitoring and enhanced patient care through a centralized software platform and clinical support services from certified diabetes care and education specialists (CDCES). SweetSpot is BioGenerator-supported and a Cortex District member.

  • SentiAR, a St. Louis-based startup, developed a system that generates interactive 3D holographic visualizations, providing physicians with a holographic guidance system for invasive cardiac procedures. SentiAR is BioGenerator-supported and a WashU IP startup.

More Articles

Alzheimers.png

FDA Clears Ground-Breaking Alzheimer's Test by...

PrecivityAD2® Becomes the First FDA-Cleared Test Powered by High Resolution Mass Spectrometry and Multiple Analyte Algorithm Score for Aiding in Diagnosis

arrow pointing right
4300_Duncan_Ave.png

St. Louis Ranked #4 Nationally Among Top 10 U.S....

St. Louis dominates emerging regions in patents and is a strong second in NIH funding with 1,855 awards totaling $1.186 billion.

arrow pointing right
32d0d98fd271f37bef1e6427b024da71.jpg

Cortex District Member BioGenerator Listed as One...

As the startup arm of BioSTL, BioGenerator creates, grows, and invests in promising St. Louis startups and entrepreneurs.

arrow pointing right
fancy footer design